Content
Non-Sedating Anxiolytic
|
Active Ingredient
Each tablet contains tofisopam 50 mg.
|
Indications
- No deprine (tofisopam) has demonstrated efficacy in a wide range of therapeutic
applications, including anxiety, functional gastrointestinal (GI) disorders, perimenopausal
symptoms, hypertension, depression, and disorders of autonomic function.
- No deprine (tofisopam) is indicated as an adjuvant therapy to control psychosomatic
symptoms such as headache, fatigue, tachycardia, sweating.
- No deprine (tofisopam) is effective as adjuvant therapy for treatment of paroxysmal
supraventricular tachycardia.
- No deprine (tofisopam) is indicated as an adjuvant therapy to improve intestinal passage
in patients with irritable colon syndrome.
- No deprine (tofisopam) is indicated as an adjuvant therapy in hypermotor dysfunction
of the biliary ducts.
- No deprine (tofisopam) is indicated for reduction of preoperative anxiety.
|